Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conor C Lynch

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Research Square|August 20, 2025
Unc-51 Like Kinase 3 (ULK3) is essential for autophagy and cell survival in multiple myelomaMarilena Tauro, Tao Li, Praneeth R Sudalagunta, et al.
Frontiers in Immunology|December 22, 2018
Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor ImmunityBrian C Betts, Frederick L Locke, Elizabeth M Sagatys, et al.
Research Square|May 5, 2025
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple MyelomaRafael Renatino Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Blood|June 11, 2026
Product-Intrinsic NF-κB-Driven Transcriptional Programs Connote Durability of CAR-T Response in Multiple MyelomaJerald D Noble, Barbara C Peixoto, Meghan A Menges, et al.
Cancer Research|June 3, 2026
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple MyelomaRafael R Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Cancer Research|October 30, 2024
The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple MyelomaPraneeth Reddy Sudalagunta, Rafael R Canevarolo, Mark B Meads, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Research Square|August 20, 2025
Unc-51 Like Kinase 3 (ULK3) is essential for autophagy and cell survival in multiple myelomaMarilena Tauro, Tao Li, Praneeth R Sudalagunta, et al.
Frontiers in Immunology|December 22, 2018
Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor ImmunityBrian C Betts, Frederick L Locke, Elizabeth M Sagatys, et al.
Research Square|May 5, 2025
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple MyelomaRafael Renatino Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Blood|June 11, 2026
Product-Intrinsic NF-κB-Driven Transcriptional Programs Connote Durability of CAR-T Response in Multiple MyelomaJerald D Noble, Barbara C Peixoto, Meghan A Menges, et al.
Cancer Research|June 3, 2026
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple MyelomaRafael R Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Cancer Research|October 30, 2024
The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple MyelomaPraneeth Reddy Sudalagunta, Rafael R Canevarolo, Mark B Meads, et al.
Pageof 7